These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 9387239)
21. Dolbec D; Lehoux M; Okura M; Takamatsu D; Gottschalk M; Segura M Front Cell Infect Microbiol; 2023; 13():1228496. PubMed ID: 37545852 [No Abstract] [Full Text] [Related]
22. Identification of six novel capsular polysaccharide loci (NCL) from Streptococcus suis multidrug resistant non-typeable strains and the pathogenic characteristic of strains carrying new NCLs. Huang J; Liu X; Chen H; Chen L; Gao X; Pan Z; Wang J; Lu C; Yao H; Wang L; Wu Z Transbound Emerg Dis; 2019 Mar; 66(2):995-1003. PubMed ID: 30676694 [TBL] [Abstract][Full Text] [Related]
23. Evaluation on a Streptococcus suis vaccine using recombinant sao-l protein manufactured by bioreactors as the antigen in pigs. Hsueh KJ; Lee JW; Hou SM; Chen HS; Chang TC; Chu CY Transbound Emerg Dis; 2014 Dec; 61(6):e35-43. PubMed ID: 23489297 [TBL] [Abstract][Full Text] [Related]
24. Peptidyl isomerase PrsA is surface-associated on Streptococcus suis and offers cross-protection against serotype 9 strain. Jiang X; Yang Y; Zhou J; Liu H; Liao X; Luo J; Li X; Fang W FEMS Microbiol Lett; 2019 Jan; 366(2):. PubMed ID: 30629173 [TBL] [Abstract][Full Text] [Related]
25. Characterization of porcine dendritic cell response to Streptococcus suis. Lecours MP; Segura M; Lachance C; Mussa T; Surprenant C; Montoya M; Gottschalk M Vet Res; 2011 Jun; 42(1):72. PubMed ID: 21635729 [TBL] [Abstract][Full Text] [Related]
26. Application of phage display technology for the production of antibodies against Streptococcus suis serotype 2. Sulong P; Anudit N; Nuanualsuwan S; Mariela S; Khantasup K PLoS One; 2021; 16(10):e0258931. PubMed ID: 34699547 [TBL] [Abstract][Full Text] [Related]
27. Characterization and Protective Activity of Monoclonal Antibodies Directed against Goyette-Desjardins G; Lacouture S; Auger JP; Roy R; Gottschalk M; Segura M Pathogens; 2019 Sep; 8(3):. PubMed ID: 31500262 [No Abstract] [Full Text] [Related]
28. Live Streptococcus suis type 5 strain XS045 provides cross-protection against infection by strains of types 2 and 9. Jiang X; Yang Y; Zhu L; Gu Y; Shen H; Shan Y; Li X; Wu J; Fang W Vaccine; 2016 Dec; 34(51):6529-6538. PubMed ID: 27349838 [TBL] [Abstract][Full Text] [Related]
29. Streptococcus suis Serotype 2 Capsule In Vivo. Auger JP; Meekhanon N; Okura M; Osaki M; Gottschalk M; Sekizaki T; Takamatsu D Emerg Infect Dis; 2016 Oct; 22(10):1793-6. PubMed ID: 27648583 [TBL] [Abstract][Full Text] [Related]
30. Capsular polysaccharide switching in Streptococcus suis modulates host cell interactions and virulence. Okura M; Auger JP; Shibahara T; Goyette-Desjardins G; Van Calsteren MR; Maruyama F; Kawai M; Osaki M; Segura M; Gottschalk M; Takamatsu D Sci Rep; 2021 Mar; 11(1):6513. PubMed ID: 33753801 [TBL] [Abstract][Full Text] [Related]
31. Role of the capsular polysaccharide as a virulence factor for Streptococcus suis serotype 14. Roy D; Auger JP; Segura M; Fittipaldi N; Takamatsu D; Okura M; Gottschalk M Can J Vet Res; 2015 Apr; 79(2):141-6. PubMed ID: 25852230 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of the immunogenicity and the protective efficacy of a novel identified immunogenic protein, SsPepO, of Streptococcus suis serotype 2. Li J; Xia J; Tan C; Zhou Y; Wang Y; Zheng C; Chen H; Bei W Vaccine; 2011 Sep; 29(38):6514-9. PubMed ID: 21767591 [TBL] [Abstract][Full Text] [Related]
33. Monoclonal antibodies with specificities for Streptococcus pneumoniae group 9 capsular polysaccharides. Kolberg J; Jones C FEMS Immunol Med Microbiol; 1998 Apr; 20(4):249-55. PubMed ID: 9626929 [TBL] [Abstract][Full Text] [Related]
34. Explaining the Serological Characteristics of Streptococcus suis Serotypes 1 and 1/2 from Their Capsular Polysaccharide Structure and Biosynthesis. Van Calsteren MR; Goyette-Desjardins G; Gagnon F; Okura M; Takamatsu D; Roy R; Gottschalk M; Segura M J Biol Chem; 2016 Apr; 291(16):8387-98. PubMed ID: 26912653 [TBL] [Abstract][Full Text] [Related]
35. Specificity and protective activity of murine monoclonal antibodies directed against the capsular polysaccharide of type III group B streptococci. Teti G; Calapai M; Calogero G; Tomasello F; Mancuso G; Galli A; Riggio G Hybridoma; 1992 Feb; 11(1):13-22. PubMed ID: 1371105 [TBL] [Abstract][Full Text] [Related]
36. Colloidal gold-based immunochromatographic strip test compromising optimised combinations of anti-S. suis capsular polysaccharide polyclonal antibodies for detection of Streptococcus suis. Nakayama T; Zhao J; Takeuchi D; Kerdsin A; Chiranairadul P; Areeratana P; Loetthong P; Pienpringam A; Akeda Y; Oishi K Biosens Bioelectron; 2014 Oct; 60():175-9. PubMed ID: 24800681 [TBL] [Abstract][Full Text] [Related]
37. Immunization of pigs against Streptococcus suis serotype 2 infection using a live avirulent strain. Busque P; Higgins R; Caya F; Quessy S Can J Vet Res; 1997 Oct; 61(4):275-9. PubMed ID: 9342451 [TBL] [Abstract][Full Text] [Related]
38. Streptococcus suis serotype 2 strains can induce the formation of neutrophil extracellular traps and evade trapping. Zhao J; Pan S; Lin L; Fu L; Yang C; Xu Z; Wei Y; Jin M; Zhang A FEMS Microbiol Lett; 2015 Mar; 362(6):. PubMed ID: 25673283 [TBL] [Abstract][Full Text] [Related]
39. Distribution of capsular types and production of muramidase-released protein (MRP) and extracellular factor (EF) of Streptococcus suis strains isolated from diseased pigs in seven European countries. Wisselink HJ; Smith HE; Stockhofe-Zurwieden N; Peperkamp K; Vecht U Vet Microbiol; 2000 Jun; 74(3):237-48. PubMed ID: 10808092 [TBL] [Abstract][Full Text] [Related]
40. Antibody response specific to the capsular polysaccharide is impaired in Streptococcus suis serotype 2-infected animals. Calzas C; Lemire P; Auray G; Gerdts V; Gottschalk M; Segura M Infect Immun; 2015 Jan; 83(1):441-53. PubMed ID: 25385801 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]